Sunshine Biopharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $98.1K
Liabilities Breakdown FY2019
Total Liabilities: $833.5K
Asset Breakdown
Total Assets: $98.1K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $40.5K | 41.3% |
| Accounts Receivable | $430 | 0.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $32.5K | 33.1% |
| Goodwill | $665.7K | 678.3% |
| Intangible Assets | $0 | 0.0% |
Liabilities Breakdown
Total Liabilities: $833.5K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $96.9K | 11.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $736.6K | 88.4% |